Moleculin Biotech, Inc. (MBRX)
NASDAQ: MBRX · Real-Time Price · USD
2.649
-0.021 (-0.78%)
Nov 21, 2024, 11:42 AM EST - Market open

Moleculin Biotech Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2015
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2015
Market Capitalization
82930535042
Upgrade
Market Cap Growth
-36.61%-5.48%-42.91%5.47%20.43%48.31%
Upgrade
Enterprise Value
-15-20-223827
Upgrade
Last Close Price
2.6712.8815.9027.9071.7482.36
Upgrade
PB Ratio
1.071.100.580.672.842.69
Upgrade
P/TBV Ratio
-1.920.740.787.629.46
Upgrade
Debt / Equity Ratio
0.070.020.010.000.020.02
Upgrade
Quick Ratio
1.683.478.9619.595.203.01
Upgrade
Current Ratio
2.083.869.4620.025.893.78
Upgrade
Return on Equity (ROE)
-141.49%-76.07%-44.25%-32.85%-104.14%-88.50%
Upgrade
Return on Assets (ROA)
-57.45%-38.73%-27.06%-25.38%-45.48%-48.87%
Upgrade
Return on Capital (ROIC)
-82.70%-46.71%-29.06%-29.54%-72.61%-72.48%
Upgrade
Earnings Yield
-386.85%-103.79%-95.65%-29.90%-34.44%-31.56%
Upgrade
FCF Yield
-311.53%-84.46%-91.30%-35.69%-36.01%-41.22%
Upgrade
Buyback Yield / Dilution
-37.97%-3.60%-6.43%-172.97%-45.07%-57.20%
Upgrade
Total Shareholder Return
-37.97%-3.60%-6.43%-172.97%-45.07%-57.20%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.